跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XPOVIO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
XPOVIO
Authorized
STANDARD
XPOVIO
forus therapeutics inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b026e90e7ea10c70
Company
forus therapeutics inc.
Type
Standard
Approval Details
Approval Id
b026e90e7ea10c70
Drug Approval Canada Name
XPOVIO
Product Name
XPOVIO
Status
Marketed
Status Date
2022-07-07
Original Market Date
2022-07-07
Din
02527677
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XX66 SELINEXOR
Atc Name
l 01 xx 66
Aig Number
0163741001
Company Name
forus therapeutics inc.
Company Address
129, 200 North Service Road West, Oakville, Ontario, Canada, L6M 2Y1
Active Ingredients
SELINEXOR
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b026e90e7ea10c70
Type
Standard
Back to Health Canada Approvals